U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Diltiazem Hydrochloride Injection
Status: Resolved
»Duration of Shortage: 02/21/2018 - 05/22/2024
»Therapeutic Categories: Cardiovascular

Expand all

Hikma Pharmaceuticals USA, Inc. (Revised 05/22/2024)

Company Contact Information:
800-631-2174

Presentation
  • Injection, 5 mg/1 mL (NDC 0641-6013-10)
  • Injection, 5 mg/1 mL (NDC 0641-6014-10)
  • Injection, 5 mg/1 mL (NDC 0641-6015-10)
Note:
  • N/A

Hospira, Inc., a Pfizer Company (Revised 05/22/2024)

Company Contact Information:
844-646-4398

Presentation
  • Diltiazem Hydrochloride, Injection, 100 mg (NDC 0409-4350-03)
Note:
  • N/A

Sagent Pharmaceuticals (Reverified 05/22/2024)

Company Contact Information:
866-625-1618

Presentation
  • Injection, 5 mg/1 mL (NDC 70860-301-05)
  • Injection, 5 mg/1 mL (NDC 70860-301-10)
  • Injection, 5 mg/1 mL (NDC 70860-301-25)
Note:
  • N/A
Back to Top